Bafna Pharmaceuticals Ltd.

•

₹ 242.452%

2026-08-21

bafnapharma.comBSE: 532989NSE: BAFNAPH

Market Cap₹ 585 Cr.

Current Price₹ 238

High / Low₹ 291 / 91

Stock P/E—

Book Value—

Price to Book—

Dividend Yield0.00 %

ROCE-3.0 %

ROE-25.4 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

Company is almost debt free
Operating margins have improved to 3.5% from -7.0%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.13x)
Company generates healthy free cash flow

CONS

Company is loss-making at the operating / net level
Company has a low return on equity of -45.8% over last 3 years
Operating cash flow has been negative in recent years
Company has a low return on capital employed of -10.7%
Interest coverage is weak at -18.7x - earnings barely cover interest
Promoter holding has decreased over last 2 years: -13.3pp

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Sales Qtr Rs.Cr.	Qtr Sales Var %	ROCE %	OPM %
1.	SUNPHARMA	1898.00	37.65	455393.78	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	8525.00	77.37	226311.96	0.35	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5013.00	87.43	190678.41	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1416.00	33.94	114392.01	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1105.00	24.42	110224.17	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LUPIN	2220.00	18.36	101506.15	0.81	1416.98	16.01	8276.89	34.28	28.86	29.59
7.	MANKIND	2391.00	48.34	98747.34	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
8.	DRREDDY	1171.00	30.33	97740.54	0.68	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LAURUSLABS	1807.00	89.30	97634.42	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
10.	AUROPHARMA	1615.15	25.03	92932.16	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	BIOCON	414.30	136.32	67518.23	0.12	136.80	53.36	4336.00	10.89	3.26	19.54
12.	BAFNAPH	247.10	0.00	584.55	0.00	6.04	—	131.33	—	6.31	32.32

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020
	131
	94
Operating Profit	—
OPM %	—
Other Income	-7
Interest	0
Depreciation	5
	22
Tax %	72.32%
Net Profit	6
	0
Equity Capital	24
Reserves	0
Promoter Pledge %	0.00%
Equity Capital	24
Reserves	0
Promoter Pledge %	0.00%

Mar 2020

: 131
: 94
Operating Profit: —
OPM %: —
Other Income: -7
Interest: 0
Depreciation: 5
: 22
Tax %: 72.32%
Net Profit: 6
: 0
Equity Capital: 24
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 24
Reserves: 0
Promoter Pledge %: 0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
	129	176	185	139	85	65	47	44	42
	110	153	162	115	85	71	82	57	41
Operating Profit	20	26	25	28	2	-5	-4	-13	1
OPM %	16	15	13	20	3	-7	-8	-29	3
Other Income	1	3	2	5	2	1	31	0	0
Interest	8	12	13	13	13	11	7	2	0
Depreciation	6	8	9	6	5	4	4	3	3
	5	5	2	6	-15	-20	-15	-18	-2
Tax %	65	27	42	-3	1	4	-15	-6	0
Net Profit	2	4	1	6	-15	-19	-17	-19	-2
EPS	0	0	0	0	0	0	0	0	0
Dividend Payout %	0	28	0	0	0	0	0	0	0
Minority Interest	-0	-0	-0	-0	1	0	0	-1	-0
Share of Associates	0	0	0	0	0	0	0	0	0
Adjusted EPS	1	2	1	3	-8	-10	-7	-8	-9
Minority Interest	-0	-0	-0	-0	1	0	0	-1	-0
Share of Associates	0	0	0	0	0	0	0	0	0
Adjusted EPS	1	2	1	3	-8	-10	-7	-8	-9

Mar 2012

: 129
: 110
Operating Profit: 20
OPM %: 16
Other Income: 1
Interest: 8
Depreciation: 6
: 5
Tax %: 65
Net Profit: 2
EPS: 0
Dividend Payout %: 0
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 1
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 1

Mar 2013

: 176
: 153
Operating Profit: 26
OPM %: 15
Other Income: 3
Interest: 12
Depreciation: 8
: 5
Tax %: 27
Net Profit: 4
EPS: 0
Dividend Payout %: 28
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 2
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 2

Mar 2014

: 185
: 162
Operating Profit: 25
OPM %: 13
Other Income: 2
Interest: 13
Depreciation: 9
: 2
Tax %: 42
Net Profit: 1
EPS: 0
Dividend Payout %: 0
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 1
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 1

Mar 2015

: 139
: 115
Operating Profit: 28
OPM %: 20
Other Income: 5
Interest: 13
Depreciation: 6
: 6
Tax %: -3
Net Profit: 6
EPS: 0
Dividend Payout %: 0
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 3
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: 3

Mar 2016

: 85
: 85
Operating Profit: 2
OPM %: 3
Other Income: 2
Interest: 13
Depreciation: 5
: -15
Tax %: 1
Net Profit: -15
EPS: 0
Dividend Payout %: 0
Minority Interest: 1
Share of Associates: 0
Adjusted EPS: -8
Minority Interest: 1
Share of Associates: 0
Adjusted EPS: -8

Mar 2017

: 65
: 71
Operating Profit: -5
OPM %: -7
Other Income: 1
Interest: 11
Depreciation: 4
: -20
Tax %: 4
Net Profit: -19
EPS: 0
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: -10
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: -10

Mar 2018

: 47
: 82
Operating Profit: -4
OPM %: -8
Other Income: 31
Interest: 7
Depreciation: 4
: -15
Tax %: -15
Net Profit: -17
EPS: 0
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: -7
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: -7

Mar 2019

: 44
: 57
Operating Profit: -13
OPM %: -29
Other Income: 0
Interest: 2
Depreciation: 3
: -18
Tax %: -6
Net Profit: -19
EPS: 0
Dividend Payout %: 0
Minority Interest: -1
Share of Associates: 0
Adjusted EPS: -8
Minority Interest: -1
Share of Associates: 0
Adjusted EPS: -8

Mar 2020

: 42
: 41
Operating Profit: 1
OPM %: 3
Other Income: 0
Interest: 0
Depreciation: 3
: -2
Tax %: 0
Net Profit: -2
EPS: 0
Dividend Payout %: 0
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: -9
Minority Interest: -0
Share of Associates: 0
Adjusted EPS: -9

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: -21%
3 Years:: -13%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: 11%
3 Years:: 30%
1 Year:: 129%

RETURN ON EQUITY

10 Years:: —
5 Years:: -40%
3 Years:: -46%
Last Year:: -25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
LIABILITIES	-	-	-	-	-	-	-	-	-
Equity Capital	18	19	19	19	19	19	24	24	2
	40	46	50	53	39	20	14	-5	-7
	59	75	85	57	45	43	23	23	0
Trade Payables	58	79	42	42	38	24	29	40	13
	44	43	40	29	52	72	49	38	63
Total Liabilities	219	261	236	200	193	178	138	119	71
ASSETS	-	-	-	-	-	-	-	-	-
	76	73	69	55	53	49	45	37	35
	0	0	0	17	17	17	0	0	0
	24	22	27	16	16	17	11	9	11
	0	0	0	0	0	0	0	0	0
Cash & Bank	2	21	3	3	3	3	3	3	8
	116	144	136	109	104	93	80	70	16
Total Assets	219	261	236	200	193	178	138	119	71
Total Debt	85	100	108	69	80	82	47	46	3
Net Working Capital	15	19	21	16	27	-4	-11	-22	19
Contingent Liabilities	14	14	18	12	2	0	0	0	0
Book Value per Share	28.74	30.44	32.90	38.47	30.57	20.73	16.03	8.06	-17.93
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Total Debt	85	100	108	69	80	82	47	46	3
Net Working Capital	15	19	21	16	27	-4	-11	-22	19
Contingent Liabilities	14	14	18	12	2	0	0	0	0
Book Value per Share	28.74	30.44	32.90	38.47	30.57	20.73	16.03	8.06	-17.93
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00

Mar 2012

Equity Capital: 18
: 40
: 59
Trade Payables: 58
: 44
Total Liabilities: 219
: 76
: 0
: 24
: 0
Cash & Bank: 2
: 116
Total Assets: 219
Total Debt: 85
Net Working Capital: 15
Contingent Liabilities: 14
Book Value per Share: 28.74
Face Value: 10.00
Total Debt: 85
Net Working Capital: 15
Contingent Liabilities: 14
Book Value per Share: 28.74
Face Value: 10.00

Mar 2013

Equity Capital: 19
: 46
: 75
Trade Payables: 79
: 43
Total Liabilities: 261
: 73
: 0
: 22
: 0
Cash & Bank: 21
: 144
Total Assets: 261
Total Debt: 100
Net Working Capital: 19
Contingent Liabilities: 14
Book Value per Share: 30.44
Face Value: 10.00
Total Debt: 100
Net Working Capital: 19
Contingent Liabilities: 14
Book Value per Share: 30.44
Face Value: 10.00

Mar 2014

Equity Capital: 19
: 50
: 85
Trade Payables: 42
: 40
Total Liabilities: 236
: 69
: 0
: 27
: 0
Cash & Bank: 3
: 136
Total Assets: 236
Total Debt: 108
Net Working Capital: 21
Contingent Liabilities: 18
Book Value per Share: 32.90
Face Value: 10.00
Total Debt: 108
Net Working Capital: 21
Contingent Liabilities: 18
Book Value per Share: 32.90
Face Value: 10.00

Mar 2015

Equity Capital: 19
: 53
: 57
Trade Payables: 42
: 29
Total Liabilities: 200
: 55
: 17
: 16
: 0
Cash & Bank: 3
: 109
Total Assets: 200
Total Debt: 69
Net Working Capital: 16
Contingent Liabilities: 12
Book Value per Share: 38.47
Face Value: 10.00
Total Debt: 69
Net Working Capital: 16
Contingent Liabilities: 12
Book Value per Share: 38.47
Face Value: 10.00

Mar 2016

Equity Capital: 19
: 39
: 45
Trade Payables: 38
: 52
Total Liabilities: 193
: 53
: 17
: 16
: 0
Cash & Bank: 3
: 104
Total Assets: 193
Total Debt: 80
Net Working Capital: 27
Contingent Liabilities: 2
Book Value per Share: 30.57
Face Value: 10.00
Total Debt: 80
Net Working Capital: 27
Contingent Liabilities: 2
Book Value per Share: 30.57
Face Value: 10.00

Mar 2017

Equity Capital: 19
: 20
: 43
Trade Payables: 24
: 72
Total Liabilities: 178
: 49
: 17
: 17
: 0
Cash & Bank: 3
: 93
Total Assets: 178
Total Debt: 82
Net Working Capital: -4
Contingent Liabilities: 0
Book Value per Share: 20.73
Face Value: 10.00
Total Debt: 82
Net Working Capital: -4
Contingent Liabilities: 0
Book Value per Share: 20.73
Face Value: 10.00

Mar 2018

Equity Capital: 24
: 14
: 23
Trade Payables: 29
: 49
Total Liabilities: 138
: 45
: 0
: 11
: 0
Cash & Bank: 3
: 80
Total Assets: 138
Total Debt: 47
Net Working Capital: -11
Contingent Liabilities: 0
Book Value per Share: 16.03
Face Value: 10.00
Total Debt: 47
Net Working Capital: -11
Contingent Liabilities: 0
Book Value per Share: 16.03
Face Value: 10.00

Mar 2019

Equity Capital: 24
: -5
: 23
Trade Payables: 40
: 38
Total Liabilities: 119
: 37
: 0
: 9
: 0
Cash & Bank: 3
: 70
Total Assets: 119
Total Debt: 46
Net Working Capital: -22
Contingent Liabilities: 0
Book Value per Share: 8.06
Face Value: 10.00
Total Debt: 46
Net Working Capital: -22
Contingent Liabilities: 0
Book Value per Share: 8.06
Face Value: 10.00

Mar 2020

Equity Capital: 2
: -7
: 0
Trade Payables: 13
: 63
Total Liabilities: 71
: 35
: 0
: 11
: 0
Cash & Bank: 8
: 16
Total Assets: 71
Total Debt: 3
Net Working Capital: 19
Contingent Liabilities: 0
Book Value per Share: -17.93
Face Value: 10.00
Total Debt: 3
Net Working Capital: 19
Contingent Liabilities: 0
Book Value per Share: -17.93
Face Value: 10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
	29	37	2	11	1	-1	-7	-2	-34
Cash from Investing	-38	-6	-7	60	-0	-5	38	15	33
Cash from Financing	-1	-12	-13	-71	-1	6	-31	-14	7
	-9	19	-18	-0	-0	-0	0	-0	6
Free Cash Flow	29	35	-0	11	-1	-1	-7	-2	-36
OCF / Net Profit	15.35	9.13	1.11	1.71	-0.06	0.05	0.42	0.09	18.22
Cumulative 5-Year FCF	0	0	0	0	0	43	1	-1	-47
OCF / Net Profit	15.35	9.13	1.11	1.71	-0.06	0.05	0.42	0.09	18.22
Cumulative 5-Year FCF	0	0	0	0	0	43	1	-1	-47

Mar 2012

: 29
Cash from Investing: -38
Cash from Financing: -1
: -9
Free Cash Flow: 29
OCF / Net Profit: 15.35
Cumulative 5-Year FCF: 0
OCF / Net Profit: 15.35
Cumulative 5-Year FCF: 0

Mar 2013

: 37
Cash from Investing: -6
Cash from Financing: -12
: 19
Free Cash Flow: 35
OCF / Net Profit: 9.13
Cumulative 5-Year FCF: 0
OCF / Net Profit: 9.13
Cumulative 5-Year FCF: 0

Mar 2014

: 2
Cash from Investing: -7
Cash from Financing: -13
: -18
Free Cash Flow: -0
OCF / Net Profit: 1.11
Cumulative 5-Year FCF: 0
OCF / Net Profit: 1.11
Cumulative 5-Year FCF: 0

Mar 2015

: 11
Cash from Investing: 60
Cash from Financing: -71
: -0
Free Cash Flow: 11
OCF / Net Profit: 1.71
Cumulative 5-Year FCF: 0
OCF / Net Profit: 1.71
Cumulative 5-Year FCF: 0

Mar 2016

: 1
Cash from Investing: -0
Cash from Financing: -1
: -0
Free Cash Flow: -1
OCF / Net Profit: -0.06
Cumulative 5-Year FCF: 0
OCF / Net Profit: -0.06
Cumulative 5-Year FCF: 0

Mar 2017

: -1
Cash from Investing: -5
Cash from Financing: 6
: -0
Free Cash Flow: -1
OCF / Net Profit: 0.05
Cumulative 5-Year FCF: 43
OCF / Net Profit: 0.05
Cumulative 5-Year FCF: 43

Mar 2018

: -7
Cash from Investing: 38
Cash from Financing: -31
: 0
Free Cash Flow: -7
OCF / Net Profit: 0.42
Cumulative 5-Year FCF: 1
OCF / Net Profit: 0.42
Cumulative 5-Year FCF: 1

Mar 2019

: -2
Cash from Investing: 15
Cash from Financing: -14
: -0
Free Cash Flow: -2
OCF / Net Profit: 0.09
Cumulative 5-Year FCF: -1
OCF / Net Profit: 0.09
Cumulative 5-Year FCF: -1

Mar 2020

: -34
Cash from Investing: 33
Cash from Financing: 7
: 6
Free Cash Flow: -36
OCF / Net Profit: 18.22
Cumulative 5-Year FCF: -47
OCF / Net Profit: 18.22
Cumulative 5-Year FCF: -47

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
PER SHARE	-	-	-	-	-	-	-	-	-
EPS (₹)	1.00	2.12	0.75	3.31	-7.52	-10.23	-7.07	-8.40	-9.17
Book Value (₹)	28.74	30.44	32.90	38.47	30.57	20.73	16.03	8.06	-17.93
Dividend per Share (₹)	0.00	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	4.47	6.57	5.60	6.54	-5.51	-8.17	-5.47	-6.71	5.85
PROFITABILITY	-	-	-	-	-	-	-	-	-
Operating Margin %	15.51%	14.39%	13.32%	20.29%	2.89%	-7.04%	-8.06%	-29.09%	3.48%
Net Margin %	1.47%	2.26%	0.78%	4.45%	-17.53%	-29.34%	-35.85%	-44.38%	-4.43%
ROE %	3.61%	7.32%	2.44%	9.34%	-23.51%	-40.67%	-44.15%	-67.95%	-25.42%
ROCE %	9.50%	11.44%	9.53%	12.60%	-1.70%	-6.77%	-7.42%	-21.59%	-2.99%
	0.87%	1.67%	0.58%	2.86%	-7.72%	-10.50%	-10.68%	-15.02%	-1.97%
EFFICIENCY	-	-	-	-	-	-	-	-	-
Debtor Days	236	181	186	243	331	335	302	205	133
Inventory Days	67	47	49	57	69	91	106	83	89
Payable Days	248	204	177	197	232	227	287	520	588
	55	24	58	103	168	199	121	-231	-366
FINANCIAL HEALTH	-	-	-	-	-	-	-	-	-
Debt to Equity (x)	1.62x	1.76x	1.76x	0.96x	1.41x	2.13x	1.23x	2.43x	-0.71x
Interest Coverage (x)	1.65x	1.46x	1.19x	1.45x	-0.18x	-0.77x	-1.12x	-7.60x	-18.72x
	1.12x	1.12x	1.16x	1.14x	1.29x	0.95x	0.81x	0.68x	2.11x
GROWTH	-	-	-	-	-	-	-	-	-
Revenue Growth %	0.00%	36.64%	5.44%	-25.12%	-38.53%	-23.86%	-27.39%	-7.51%	-2.65%
Operating Profit Growth %	0.00%	26.82%	-3.23%	14.77%	-91.20%	-287.13%	18.63%	-233.99%	111.65%
Net Profit Growth %	0.00%	110.61%	-64.01%	330.60%	-343.44%	-28.52%	13.11%	-14.49%	90.27%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VALUATION	-	-	-	-	-	-	-	-	-
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x

Mar 2012

EPS (₹): 1.00
Book Value (₹): 28.74
Dividend per Share (₹): 0.00
Cash EPS (₹): 4.47
Operating Margin %: 15.51%
Net Margin %: 1.47%
ROE %: 3.61%
ROCE %: 9.50%
: 0.87%
Debtor Days: 236
Inventory Days: 67
Payable Days: 248
: 55
Debt to Equity (x): 1.62x
Interest Coverage (x): 1.65x
: 1.12x
Revenue Growth %: 0.00%
Operating Profit Growth %: 0.00%
Net Profit Growth %: 0.00%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2013

EPS (₹): 2.12
Book Value (₹): 30.44
Dividend per Share (₹): 0.60
Cash EPS (₹): 6.57
Operating Margin %: 14.39%
Net Margin %: 2.26%
ROE %: 7.32%
ROCE %: 11.44%
: 1.67%
Debtor Days: 181
Inventory Days: 47
Payable Days: 204
: 24
Debt to Equity (x): 1.76x
Interest Coverage (x): 1.46x
: 1.12x
Revenue Growth %: 36.64%
Operating Profit Growth %: 26.82%
Net Profit Growth %: 110.61%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2014

EPS (₹): 0.75
Book Value (₹): 32.90
Dividend per Share (₹): 0.00
Cash EPS (₹): 5.60
Operating Margin %: 13.32%
Net Margin %: 0.78%
ROE %: 2.44%
ROCE %: 9.53%
: 0.58%
Debtor Days: 186
Inventory Days: 49
Payable Days: 177
: 58
Debt to Equity (x): 1.76x
Interest Coverage (x): 1.19x
: 1.16x
Revenue Growth %: 5.44%
Operating Profit Growth %: -3.23%
Net Profit Growth %: -64.01%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2015

EPS (₹): 3.31
Book Value (₹): 38.47
Dividend per Share (₹): 0.00
Cash EPS (₹): 6.54
Operating Margin %: 20.29%
Net Margin %: 4.45%
ROE %: 9.34%
ROCE %: 12.60%
: 2.86%
Debtor Days: 243
Inventory Days: 57
Payable Days: 197
: 103
Debt to Equity (x): 0.96x
Interest Coverage (x): 1.45x
: 1.14x
Revenue Growth %: -25.12%
Operating Profit Growth %: 14.77%
Net Profit Growth %: 330.60%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2016

EPS (₹): -7.52
Book Value (₹): 30.57
Dividend per Share (₹): 0.00
Cash EPS (₹): -5.51
Operating Margin %: 2.89%
Net Margin %: -17.53%
ROE %: -23.51%
ROCE %: -1.70%
: -7.72%
Debtor Days: 331
Inventory Days: 69
Payable Days: 232
: 168
Debt to Equity (x): 1.41x
Interest Coverage (x): -0.18x
: 1.29x
Revenue Growth %: -38.53%
Operating Profit Growth %: -91.20%
Net Profit Growth %: -343.44%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2017

EPS (₹): -10.23
Book Value (₹): 20.73
Dividend per Share (₹): 0.00
Cash EPS (₹): -8.17
Operating Margin %: -7.04%
Net Margin %: -29.34%
ROE %: -40.67%
ROCE %: -6.77%
: -10.50%
Debtor Days: 335
Inventory Days: 91
Payable Days: 227
: 199
Debt to Equity (x): 2.13x
Interest Coverage (x): -0.77x
: 0.95x
Revenue Growth %: -23.86%
Operating Profit Growth %: -287.13%
Net Profit Growth %: -28.52%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2018

EPS (₹): -7.07
Book Value (₹): 16.03
Dividend per Share (₹): 0.00
Cash EPS (₹): -5.47
Operating Margin %: -8.06%
Net Margin %: -35.85%
ROE %: -44.15%
ROCE %: -7.42%
: -10.68%
Debtor Days: 302
Inventory Days: 106
Payable Days: 287
: 121
Debt to Equity (x): 1.23x
Interest Coverage (x): -1.12x
: 0.81x
Revenue Growth %: -27.39%
Operating Profit Growth %: 18.63%
Net Profit Growth %: 13.11%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2019

EPS (₹): -8.40
Book Value (₹): 8.06
Dividend per Share (₹): 0.00
Cash EPS (₹): -6.71
Operating Margin %: -29.09%
Net Margin %: -44.38%
ROE %: -67.95%
ROCE %: -21.59%
: -15.02%
Debtor Days: 205
Inventory Days: 83
Payable Days: 520
: -231
Debt to Equity (x): 2.43x
Interest Coverage (x): -7.60x
: 0.68x
Revenue Growth %: -7.51%
Operating Profit Growth %: -233.99%
Net Profit Growth %: -14.49%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2020

EPS (₹): -9.17
Book Value (₹): -17.93
Dividend per Share (₹): 0.00
Cash EPS (₹): 5.85
Operating Margin %: 3.48%
Net Margin %: -4.43%
ROE %: -25.42%
ROCE %: -2.99%
: -1.97%
Debtor Days: 133
Inventory Days: 89
Payable Days: 588
: -366
Debt to Equity (x): -0.71x
Interest Coverage (x): -18.72x
: 2.11x
Revenue Growth %: -2.65%
Operating Profit Growth %: 111.65%
Net Profit Growth %: 90.27%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Shareholding Pattern

Numbers in percentages

TRADES

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	88.30	88.30	88.30	75.00	75.00	75.00	75.00	75.00	75.00
	0.00	0.00	0.00	8.53	9.34	9.34	9.34	9.34	9.34
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	11.70	11.70	11.70	16.47	15.66	15.66	15.66	15.66	15.66

Jun 2024

: 88.30
: 0.00
DIIs: 0.00
Government: 0.00
: 11.70

Sep 2024

: 88.30
: 0.00
DIIs: 0.00
Government: 0.00
: 11.70

Dec 2024

: 88.30
: 0.00
DIIs: 0.00
Government: 0.00
: 11.70

Mar 2025

: 75.00
: 8.53
DIIs: 0.00
Government: 0.00
: 16.47

Jun 2025

: 75.00
: 9.34
DIIs: 0.00
Government: 0.00
: 15.66

Sep 2025

: 75.00
: 9.34
DIIs: 0.00
Government: 0.00
: 15.66

Dec 2025

: 75.00
: 9.34
DIIs: 0.00
Government: 0.00
: 15.66

Mar 2026

: 75.00
: 9.34
DIIs: 0.00
Government: 0.00
: 15.66

Jun 2026

: 75.00
: 9.34
DIIs: 0.00
Government: 0.00
: 15.66

Documents

Announcements

Shareholders meeting
2026-08-19 - Bafna Pharmaceuticals Limited has informed the Exchange regarding Notice of 31st Annual General Meeting of the Company to be held on September 11, 2026 along with the Annual Report for F.Y 2025-2026
Copy of Newspaper Publication
2026-08-14 - Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026 as published in ''Business Standard'' and ''Makkal Kural'' on August 13, 2026

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

Nothing filed yet.